PB
IMGN

Pinnacle Bancorp’s Immunogen Inc IMGN Stock Holding History

Pinnacle Bancorp’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-229
Closed -$2K – 795
2021
Q4 		$2K Hold
229
– – ﹤0.01% 703
2021
Q3 		$1K Hold
229
– – ﹤0.01% 714
2021
Q2 		$2K Hold
229
– – ﹤0.01% 702
2021
Q1 		$2K Buy
+229
New +$1.87K ﹤0.01% 703

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Bancorp's IMGN Position: Q1 2022 in Review

Pinnacle Bancorp sold out of Immunogen Inc (IMGN) in Q1 2022, closing a stake of 229 shares — an estimated $2K sold.

Pinnacle Bancorp first reported a position in IMGN in Q1 2021 and held it in 4 quarters. The position peaked at $2K in Q4 2021. 217 funds tracked by Wall St. Rank hold IMGN as of Q1 2022.

  • Pinnacle Bancorp reported no remaining Immunogen Inc position as of Q1 2022 after selling out during the quarter.
  • Pinnacle Bancorp sold 229 Immunogen Inc shares in Q1 2022, an estimated $2K.
  • Pinnacle Bancorp first reported a position in Immunogen Inc in Q1 2021 and held it in 4 quarters.
  • Pinnacle Bancorp's Immunogen Inc position peaked at $2K in Q4 2021.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2022.

Based on Pinnacle Bancorp's 13F filing for Q1 2022, filed 14 Apr 2022.